Olin (OLN) Following Fresh Earnings Optimism Does The Undervalued Case Still Hold

Analyst expectations around Olin (OLN) have taken center stage ahead of its June 2026 quarter earnings report, with projections calling for higher earnings even as revenue estimates point to a lower top line.

See our latest analysis for Olin.

Olin's recent momentum has been mixed, with the share price up 5.5% over the past week and 10.5% over the past month, but still down 13.3% over 90 days. The 1 year total shareholder return of 12.8% contrasts with a much weaker 3 year record, suggesting sentiment has improved in the short term as investors reassess earnings risk.

If this shift in expectations has you looking beyond chemicals, it could be a good moment to see what other trends are forming in fast growing areas such as 35 power grid technology and infrastructure stocks

After a sharp bounce in Olin, set against a still weak three-year record and a reported net loss of $184.9 million on $6.7 billion of revenue, does the current valuation still tilt the risk-reward in buyers' favor, or has the easy upside already been claimed?

Most Popular Narrative: 11.7% Undervalued

On the latest fair value work, Olin is assessed at $26.29 per share against a last close of $23.20. This frames the current debate around a potential valuation gap driven by future earnings recovery.

Structural cost reductions and a shift to higher-margin specialty chemicals are set to enhance earnings stability and profitability. Strong demand for core chemicals, disciplined capital returns, and industry rationalization position Olin for sustained growth and improved shareholder value.

Read the complete narrative.

Want to see what sits behind that fair value gap for Olin? The narrative leans heavily on a profit turnaround, firmer margins, and a different earnings mix. Curious which forecasts have to land for that to hold up? The full breakdown makes those assumptions clear.

Result: Fair Value of $26.29 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this depends on Olin avoiding prolonged global overcapacity in key chemicals and effectively managing pressure on Winchester ammunition margins, both of which could undermine that valuation gap.

Find out about the key risks to this Olin narrative.

Next Steps

With sentiment on Olin split between concern and optimism, this is a moment to move quickly, test the narrative against the numbers, and weigh both sides using the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Olin?

If the debate around Olin has sharpened your focus, do not leave it there. Widen your opportunity set with a few high quality stock ideas right now.

• Target consistent compounding potential by scanning companies with strong cash flows and attractive valuations through the 49 high quality undervalued stocks.
• Prioritize staying power in tougher conditions by focusing on companies screened for robust finances using the solid balance sheet and fundamentals stocks screener (49 results).
• Hunt for potential future leaders hiding in plain sight by running a search built around the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com